Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026)
Senseonics Holdings (SENS) reported Cash & Current Investments of $64.3 million for Q1 2026, little changed year-over-year from $64.2 million in Q1 2025, and up 58.63% quarter-over-quarter from $40.5 million in Q4 2025.
Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Cash & Current Investments data on file, last reported at $64.3 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $64.3 million, changed 0.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.3 million (changed 0.13% YoY), and the FY2025 annual result was $40.5 million, down 45.87% from the prior year.
- Cash & Current Investments improved to $64.3 million in Q1 2026 per SENS's latest filing, from $40.5 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $281.7 million in Q3 2022 and troughed at $35.2 million in Q2 2024.
- A 5-year average of $136.1 million and a median of $109.5 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments jumped 3032.97% in 2022, then plunged 70.1% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $109.4 million in 2022, then advanced by 0.09% to $109.5 million in 2023, then sank by 31.56% to $74.9 million in 2024, then tumbled by 45.87% to $40.5 million in 2025, then soared by 58.63% to $64.3 million in 2026.
- Business Quant data shows SENS's Cash & Current Investments at $64.3 million in Q1 2026, $40.5 million in Q4 2025, and $187.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Senseonics Holdings | 329.46 Mn | 265.14 Mn | 6.94 Mn | 64.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.32 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 187.49 Mn |
| Jun 30, 2025 | 126.41 Mn |
| Mar 31, 2025 | 64.24 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Sep 30, 2024 | 74.82 Mn |
| Jun 30, 2024 | 35.17 Mn |
| Mar 31, 2024 | 99.02 Mn |
| Dec 31, 2023 | 109.46 Mn |
| Sep 30, 2023 | 195.05 Mn |
| Jun 30, 2023 | 117.62 Mn |
| Mar 31, 2023 | 219.96 Mn |
| Dec 31, 2022 | 109.36 Mn |
| Sep 30, 2022 | 281.72 Mn |
| Jun 30, 2022 | 244.26 Mn |
| Mar 31, 2022 | 269.66 Mn |
| Dec 31, 2021 | 100.71 Mn |
| Sep 30, 2021 | 98.96 Mn |
| Jun 30, 2021 | 308.34 Mn |